...
首页> 外文期刊>Journal of cardiovascular electrophysiology >Simplified 'ATP test' for noninvasive diagnosis of dual AV nodal physiology and assessment of results of slow pathway ablation in patients with AV nodal reentrant tachycardia.
【24h】

Simplified 'ATP test' for noninvasive diagnosis of dual AV nodal physiology and assessment of results of slow pathway ablation in patients with AV nodal reentrant tachycardia.

机译:简化的“ ATP测试”,用于无创性双重AV结节生理诊断和评估AV结折返性心动过速患者的慢路径消融结果。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: We recently reported that administration of adenosine triphosphate (ATP) during sinus rhythm identifies dual AV nodal physiology (DAVNP) in 76% of patients with inducible sustained AV nodal reentrant tachycardia (AVNRT) at electrophysiologic (EP) study. In that report, however, the ATP test was considered positive for DAVNP only when the results were reproducible at a given dose of ATP. The aim of the present study was to assess the value of a simplified ATP test for noninvasive diagnosis of DAVNP and abolition or modification of the slow pathway (SP) after radiofrequency ablation (RFA) in patients with inducible sustained AVNRT. METHODS AND RESULTS: The value of a single dose of ATP was studied in 105 patients with inducible sustained AVNRT and in 31 control patients before placement of EP catheters in the cardiac chambers. ATP (10 to 60 mg, in 10-mg increments) was injected during sinus rhythm until ECG signs of DAVNP (> or = 50 msec increase or decrease in PR interval in two consecutive beats, or occurrence of > or = 1 AV nodal echo beat) or > or = second-degree AV block was observed. DAVNP was observed in only 1 (3.2%) control patient. The test could be completed in 96 study patients. DAVNP was found by ATP test in 72 (75%) patients, whereas it was diagnosed by EP criteria in 82 (85%) patients. DAVNP by ATP test disappeared in 27 (96%) of 28 patients who underwent SP abolition and in 18 (60%) of 30 patients who underwent SP modification. In the 12 patients with persistent DAVNP determined by ATP test after SP modification, the number of beats conducted over the SP was significantly reduced (from 6.3+/-3.3 to 2.5+/-2.2 beats; P = 0.002). CONCLUSION: A single administration of ATP during sinus rhythm (at a given dose) enables noninvasive diagnosis of DAVNP in a high percentage of patients with inducible AVNRT and reliably confirms the results of RFA of the SP.
机译:简介:我们最近报道,在电生理(EP)研究中,在窦性心律期间给予三磷酸腺苷(ATP)可在76%的诱导型持续性AV结折返性心动过速(AVNRT)患者中识别双重AV节点生理(DAVNP)。但是,在该报告中,只有当结果在给定的ATP剂量下可再现时,ATP测试才被视为DAVNP阳性。本研究的目的是评估简化的ATP测试对DAVNP的无创性诊断以及在射频消融(RFA)后可诱导的持续性AVNRT患者中废除或修饰慢路径(SP)的价值。方法和结果:在将EP导管置入心腔之前,对105例可诱导的持续性AVNRT患者和31例对照患者进行了单剂量ATP的研究。在窦性心律期间注射ATP(10至60 mg,以10 mg为增量),直到心电图DAVNP征兆(>或= 50毫秒,连续两次搏动中PR间隔增加或减少,或出现>或= 1 AV结节跳动)或>或=二级房室传导阻滞。仅1名(3.2%)对照患者观察到DAVNP。该测试可以在96名研究患者中完成。 DATPNP在ATP测试中被发现在72名患者中(75%),而EP标准在82名患者中被诊断(85%)。 ATP检验的DAVNP在28例行SP消融的患者中有27例(96%)消失,在30例行SP改变的患者中18例(60%)消失。在修改SP后通过ATP测试确定的12例持续性DAVNP患者中,通过SP进行的搏动次数显着减少(从6.3 +/- 3.3降至2.5 +/- 2.2搏动; P = 0.002)。结论:在窦性心律(给定剂量)期间单次施用ATP可以在高百分比的可诱导性AVNRT患者中无创诊断DAVNP,并可靠地证实SP的RFA结果。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号